KIF14–AKT axis regulates ferroptosis sensitivity in triple-negative breast cancer
Open Life Sciences · 23.01.2026 · 21 (1)
DOI: 10.1515/biol-2025-1324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Life Sciences, online erschienen am 04.05.2026. Verfasst von Chunyu Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Yunkang School of Medicine and Health, Guangzhou Nanfang College, Guangzhou 510080, China. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited targeted treatment options. Ferroptosis has emerged as a potential therapeutic vulnerability in TNBC, but its upstream regulation remains incompletely defined. Here, we combined bioinformatics analysis with cell-based experiments to investigate the role of kinesin family member 14 (KIF14) in ferroptosis sensitivity. KIF14 was upregulated in TNBC datasets and associated with poor prognosis. In MDA-MB-468 cells, KIF14 knockdown reduced cell viability, increased malondialdehyde and intracellular Fe 2+ levels, and induced mitochondrial changes consistent with ferroptosis. These effects were partially reversed by ferrostatin-1. Comparison with inhibitors of apoptosis, necroptosis, and pyroptosis showed that only ferrostatin-1 produced a clear rescue effect, supporting a predominantly ferroptosis-associated phenotype. Mechanistically, KIF14 depletion reduced phosphorylation of AKT serine/threonine kinase (AKT) and altered ferroptosis-related proteins, including decreased glutathione peroxidase 4 (GPX4) and solute carrier family 7 member 11 (SLC7A11) and increased acyl-CoA synthetase long-chain family member 4 (ACSL4). The AKT activator SC79 partially reversed these biochemical and phenotypic changes. Reciprocal co-immunoprecipitation further supported an association between endogenous KIF14 and AKT. In addition, KIF14 knockdown had minimal effects on the viability of normal MCF-10A cells. Together, these findings support a functional link between KIF14, AKT signaling, and ferroptosis sensitivity in TNBC .
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yunkang School of Medicine and Health, Guangzhou Nanfang College, Guangzhou 510080, China.
Zitieren
APA
Shi, C., Fang, W., Zhu, Y., Xie, Z., & Zhang, M. (2026). KIF14–AKT axis regulates ferroptosis sensitivity in triple-negative breast cancer. Open Life Sciences, 21(1). https://doi.org/10.1515/biol-2025-1324
Vancouver
Shi C, Fang W, Zhu Y, Xie Z, Zhang M. KIF14–AKT axis regulates ferroptosis sensitivity in triple-negative breast cancer. Open Life Sciences. 2026;21(1). doi:10.1515/biol-2025-1324
BibTeX
@article{Shi2026,
author = {Shi, Chunyu and Fang, Weiyi and Zhu, Yingqi and Xie, Ziying and Zhang, Ming},
title = {KIF14–AKT axis regulates ferroptosis sensitivity in triple-negative breast cancer},
journal = {Open Life Sciences},
year = {2026},
volume = {21},
number = {1},
doi = {10.1515/biol-2025-1324}
}
EUVIMED